AIMS: Spirometry, plethysmography and impulse oscillometry (IOS) measure different aspects of lung function. These methods have not been compared for their ability to assess long- and short-acting anticholinergic agents. We therefore performed a double-blind, placebo-controlled, four-way cross-over study in 30 healthy subjects. METHODS: Single doses of tiotropium bromide (Tio) 54 and 18 mcg, ipratropium bromide (IB) 40 mcg and placebo were administered. Specific conductance (sGaw), total lung capacity (TLC), inspiratory capacity (IC) and residual volume (RV) were measured using plethysmography, while IOS measured resistance (R5-25) and reactance (RF and X5). Pulmonary function was measured for 26 h post dose. RESULTS: Tio caused significant improvements in sGaw, forced expiratory voume in 1 s (FEV(1)), maximum mid-expiratory flow (MMEF) and R5-R25 at time points up to 26 h, with no clear differences between doses. IB improved the same parameters, but only up to 8 h. The weighted mean change (0-24 h) caused by Tio 54 mcg compared with placebo for FEV(1) was 240 ml (95% confidence interval 180, 300), while for sGaw the ratio of geometric means (Tio compared with placebo) was 1.35 (1.28, 1.41). Neither drug caused consistent statistically significant changes in RF, forced vital capacity, TLC or IC over 26 h. RV was significantly improved from 8 to 24 h by Tio 54 mcg only. CONCLUSIONS: In addition to spirometry, IOS resistance measurements and sGaw can distinguish between the effects of long- and shortacting anticholinergic effects in healthy subjects.
RCT Entities:
AIMS: Spirometry, plethysmography and impulse oscillometry (IOS) measure different aspects of lung function. These methods have not been compared for their ability to assess long- and short-acting anticholinergic agents. We therefore performed a double-blind, placebo-controlled, four-way cross-over study in 30 healthy subjects. METHODS: Single doses of tiotropium bromide (Tio) 54 and 18 mcg, ipratropium bromide (IB) 40 mcg and placebo were administered. Specific conductance (sGaw), total lung capacity (TLC), inspiratory capacity (IC) and residual volume (RV) were measured using plethysmography, while IOS measured resistance (R5-25) and reactance (RF and X5). Pulmonary function was measured for 26 h post dose. RESULTS:Tio caused significant improvements in sGaw, forced expiratory voume in 1 s (FEV(1)), maximum mid-expiratory flow (MMEF) and R5-R25 at time points up to 26 h, with no clear differences between doses. IB improved the same parameters, but only up to 8 h. The weighted mean change (0-24 h) caused by Tio 54 mcg compared with placebo for FEV(1) was 240 ml (95% confidence interval 180, 300), while for sGaw the ratio of geometric means (Tio compared with placebo) was 1.35 (1.28, 1.41). Neither drug caused consistent statistically significant changes in RF, forced vital capacity, TLC or IC over 26 h. RV was significantly improved from 8 to 24 h by Tio 54 mcg only. CONCLUSIONS: In addition to spirometry, IOS resistance measurements and sGaw can distinguish between the effects of long- and shortacting anticholinergic effects in healthy subjects.
Authors: D E O'Donnell; T Flüge; F Gerken; A Hamilton; K Webb; B Aguilaniu; B Make; H Magnussen Journal: Eur Respir J Date: 2004-06 Impact factor: 16.671
Authors: Sophie J Bradley; Coen H Wiegman; Max Maza Iglesias; Kok Choi Kong; Adrian J Butcher; Bianca Plouffe; Eugénie Goupil; Julie-Myrtille Bourgognon; Timothy Macedo-Hatch; Christian LeGouill; Kirsty Russell; Stéphane A Laporte; Gabriele M König; Evi Kostenis; Michel Bouvier; Kian Fan Chung; Yassine Amrani; Andrew B Tobin Journal: Proc Natl Acad Sci U S A Date: 2016-04-08 Impact factor: 11.205
Authors: Jutta Beier; Jan van Noord; Amanda Deans; Jean Brooks; Claire Maden; Suus Baggen; Rashmi Mehta; Anthony Cahn Journal: Int J Chron Obstruct Pulmon Dis Date: 2012-03-05
Authors: Kanika Jetmalani; Nathan J Brown; Chantale Boustany; Brett G Toelle; Guy B Marks; Michael J Abramson; David P Johns; Alan L James; Michael Hunter; Arthur W Musk; Norbert Berend; Claude S Farah; David G Chapman; Cindy Thamrin; Gregory G King Journal: ERJ Open Res Date: 2021-11-08
Authors: Neil E Alexis; John C Lay; Angela Haczku; Henry Gong; William Linn; Milan J Hazucha; Brad Harris; Ruth Tal-Singer; David B Peden Journal: Environ Health Perspect Date: 2008-06 Impact factor: 9.031